MoneyWorks4Me

Lupin - Quaterly Results

03 Aug 2023 Evaluate
The sales surged to Rs. 34956.40 millions, up 27.93% for the June 2023 quarter as against Rs. 27324.90 millions during the corresponding quarter previous year.The Total revenue for the quarter ended June 2023 of  Rs. 4769.60  millions  grew by 307.03% from Rs. 1171.80 millions.OP of the company witnessed a marginal growth to 7327.60 millions from 2951.80 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 34956.40 27324.90 27.93 34956.40 27324.90 27.93 112588.30 117716.70 -4.36
Other Income 277.40 64.80 328.09 277.40 64.80 328.09 912.60 1504.20 -39.33
PBIDT 7327.60 2951.80 148.24 7327.60 2951.80 148.24 11739.20 4261.30 175.48
Interest 161.80 198.70 -18.57 161.80 198.70 -18.57 984.40 734.70 33.99
PBDT 7165.80 2753.10 160.28 7165.80 2753.10 160.28 10754.80 3526.60 204.96
Depreciation 1400.50 1303.50 7.44 1400.50 1303.50 7.44 5483.40 5141.90 6.64
PBT 5765.30 1449.60 297.72 5765.30 1449.60 297.72 5271.40 -1615.30 -426.34
TAX 995.70 277.80 258.42 995.70 277.80 258.42 1019.30 271.70 275.16
Deferred Tax -11.50 -11.60 -0.86 -11.50 -11.60 -0.86 60.40 -306.30 -119.72
PAT 4769.60 1171.80 307.03 4769.60 1171.80 307.03 4252.10 -1887.00 -325.34
Equity 910.20 909.30 0.10 910.20 909.30 0.10 910.00 909.00 0.11
PBIDTM(%) 20.96 10.80 94.05 20.96 10.80 94.05 10.43 3.62 188.03
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..